Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
68.92%
Operating Margin
29.20%
Net Margin
18.79%
Efficiency Metrics
Revenue per Expense Ratio
1.41
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
60.74%
Income Tax Rate
0.00%
EPS
1.8000000000
Balance Sheet Analysis
Current Ratio
1.86
Cash Ratio
1.15
Working Capital
$591.33M
Debt to Equity
0.93
Debt to Assets
44.32%
Equity Ratio
47.61%
Cash Flow Analysis
Operating Cash Flow Ratio
53.34%
Free Cash Flow Ratio
5.20%
CapEx to Revenue
48.14%
Dividends Paid
$255.43M
Stock Buybacks
$11.60M
Total Shareholder Returns
$267.03M
Cash Position Change
46.86%
Key Takeaways (2023 FY)
Maintained positive net income growth despite revenue changes
Increased dividend payments by 2.87%
Detailed Growth Metrics
Core Performance
Revenue
2.98%
Net Income
21.13%
EPS
20.00%
Operating Income
1.06%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
-0.22%
Operating Cash Flow
1.75%
Free Cash Flow
944.61%
Balance Sheet Health
Assets
5.59%
Debt
15.15%
Book Value per Share
-0.57%
Inventory
100.00%
Shareholder Returns
Dividends per Share
2.87%
Shares Outstanding
0.30%
Long Term Trends
3Y Revenue/Share
21.54%
5Y Revenue/Share
28.99%
3Y Dividend/Share
9.93%
5Y Dividend/Share
21.48%